Description
Pre-packaged rAAV in Serotype-DJ, constitutively express an Anti-BCMA CAR [(VL-(G4S)x4-VH)-41BB-CD3ζ] with N-terminal 3X FLAG (DDK) tag, under a enhanced CMV Promoter (which is tested strong in T cells and B cells). See Product Manual for details.
The Anti-BCMA ScFV (Click to see its sequence), is fusion with the CAR (Chimeric Antigen Receptor) of “CD8 hinge, 4-1BB co-stimulatory domain, and CD3ζ signaling domains”. Its expression can be detected by anti-FLAG (DDK tag) antibody and anti G4S (GGGGS) antibody . The following scheme showed the AAV vector’s core structure.
BCMA is expressed on the surface of plasma cells, particularly mature B cells, and plays a role in B cell development. BCMA is a target in CAR-T therapy for multiple myeloma. This CAR’s anti-BCMA use the hybrid clone 125 / 171 (Reference).
Significant strides have been made in T cell therapies targeting well-characterized tumor antigens, including CD19 / CD20, CD22, Her2, BCMA HLA-A2, TGFβ specific-CAR. Please see also Gentartet’s CAR-T Lentivirus product, click CAR-T Lentivirus Manual, and click Anti-CD19 CAR-T Manual to see all products. Please also look at our TCR Lentivirus page. Note: all products are for research use ONLY.
AAV Serotype-DJ is a synthetic serotype made from different serotypes using DNA shuffling. AAV-DJ serotype has the enhanced transduction efficiency in vitro and in vivo compared to wild-type serotypes with Broad Cell Tropism, great transduction rate in CNS, Liver, Kidney, Fibroblasts, muscle.
Titer: ~ 1×10^12 GC/mL
Size: 100ul/vial, in stock, ready to ship in overnight Dry-ice package.
Storage Buffer: PBS
CAT#: A39.DJ
